Enterprise Value
130.3M
Cash
12.46M
Avg Qtr Burn
-12.61M
Short % of Float
1.22%
Insider Ownership
69.59%
Institutional Own.
3.45%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AP-PA02 Details Cystic fibrosis | Phase 2/3 Initiation | |
AP-PA02 Details Non-Cystic Fibrosis Bronchiectasis | Phase 2 Data readout | |
AP-SA02 Details Bacterial infection | Phase 2a Initiation |